AXIOMPHARMACEUTICALS
Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

GLP-1 & metabolic

Humanin (HN)

Mitochondria-Derived Peptide · HN

Research use onlyGBP reference pricing where listedUK dispatch on catalogue items

Overview

Humanin was the first mitochondria-derived peptide (MDP) discovered, originally cloned from the occipital lobe of an Alzheimer's patient. It is a 24-amino acid peptide encoded from the 16S rRNA region of mitochondrial DNA with potent neuroprotective, cytoprotective, and anti-apoptotic properties. Research shows…

Humanin exerts its effects through multiple mechanisms. It interacts with cell surface receptors including FPRL1 and CNTFR, activating PI3K/AKT signaling pathways that promote cell survival. It blocks pro-apoptotic proteins like Bax, reduces beta-amyloid toxicity in neurons, protects against oxidative stress, and…

Originally discovered for its ability to protect against amyloid-β toxicity in neuronal cells.

Promotes mitochondrial biogenesis via PI3K/AKT signaling in PD models.

Broad neuroprotective effects against various neurotoxic insults.

Mechanism

Humanin was the first mitochondria-derived peptide (MDP) discovered, originally cloned from the occipital lobe of an Alzheimer's patient. It is a 24-amino acid peptide encoded from the 16S rRNA region of mitochondrial DNA with potent neuroprotective, cytoprotective, and anti-apoptotic properties. Research shows…

Humanin exerts its effects through multiple mechanisms. It interacts with cell surface receptors including FPRL1 and CNTFR, activating PI3K/AKT signaling pathways that promote cell survival. It blocks pro-apoptotic proteins like Bax, reduces beta-amyloid toxicity in neurons, protects against oxidative stress, and…

Originally discovered for its ability to protect against amyloid-β toxicity in neuronal cells.

Research areas

  • Humanin was the first mitochondria-derived peptide (MDP) discovered, originally cloned from the occipital lobe of an Alzheimer's patient. It is a 24-amino acid peptide encoded from the 16S rRNA region of mitochondrial DNA with potent neuroprotective, cytoprotective, and anti-apoptotic properties. Research shows…
  • Humanin exerts its effects through multiple mechanisms. It interacts with cell surface receptors including FPRL1 and CNTFR, activating PI3K/AKT signaling pathways that promote cell survival. It blocks pro-apoptotic proteins like Bax, reduces beta-amyloid toxicity in neurons, protects against oxidative stress, and…
  • Originally discovered for its ability to protect against amyloid-β toxicity in neuronal cells.
  • Promotes mitochondrial biogenesis via PI3K/AKT signaling in PD models.
  • Broad neuroprotective effects against various neurotoxic insults.

Research notes

  • Injection site reactions
  • Signs of allergic reaction
  • Unusual persistent symptoms
  • Active cancer (theoretical concern with anti-apoptotic effects)
  • Pregnancy or breastfeeding

Questions

How is humanin different from the HNG analog?

HNG (with a glycine substitution at position 14) is approximately 1000-fold more potent than native humanin. Both work via the same mitochondrial pathways, but HNG requires much lower doses—typically 0.5-2mg versus 1-5mg for standard humanin.

Is humanin safe for people with a family history of Alzheimer's?

Potentially beneficial. Humanin was originally discovered for its ability to protect against amyloid-beta toxicity. Offspring of centenarians have naturally higher humanin levels. Anyone concerned about neurodegenerative disease might consider humanin as part of a longevity protocol.

Can I combine humanin with other longevity peptides?

Yes. Humanin pairs well with MOTS-c (another mitochondrial-derived peptide), epitalon, and NAD+ precursors. These complement each other through different pathways targeting mitochondrial function, cellular aging, and neuroprotection.